General Information of the Compound
| Compound ID |
CP0404202
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3E,4S)-3-[2-[(1S,2R,4aS,5R,6R,8aR)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethylspiro[3,4,4a,6,7,8-hexahydro-1H-naphthalene-2,2'-oxirane]-1-yl]ethylidene]-4-[tert-butyl(dimethyl)silyl]oxyoxolan-2-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H44O6Si
|
||||||||||||||||||
| Molecular Weight |
480.718
|
||||||||||||||||||
| Canonical SMILES |
CC(C)(C)[Si](C)(C)O[C@@H]1COC(=O)\C1=C\C[C@@H]1[C@@]2(CO2)CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]12C
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H44O6Si/c1-23(2,3)33(6,7)32-18-14-30-22(29)17(18)8-9-20-24(4)12-11-21(28)25(5,15-27)19(24)10-13-26(20)16-31-26/h8,18-21,27-28H,9-16H2,1-7H3/b17-8+/t18-,19+,20+,21-,24-,25+,26+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QEVMEDXXEZKAFO-SSGWBGPFSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01503, Signal transducer and activator of transcription 3